O12.6. LONG-TERM EFFECTS OF VALBENAZINE ON TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA/SCHIZOAFFECTIVE DISORDER: RESULTS FROM AN OPEN-LABEL, ROLLOVER STUDY

BACKGROUND: Tardive dyskinesia (TD) is a persistent and debilitating movement disorder associated with prolonged antipsychotic use. Valbenazine (VBZ), a highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved for the treatment of TD in adults, has been evaluated in 2 prior long...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Schizophr Bull
Huvudupphovsmän: Kane, John, Marder, Stephen, Lindenmayer, Jean-Pierre, Jimenez, Roland, Farahmand, Khodayar, Siegert, Scott
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2019
Ämnen:
Oral Abstracts
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6455177/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz021.270
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk